Spampanato and Feeney contributed equally as the two co-first authors.
Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
Article first published online: 18 APR 2013
Copyright © 2013 The Authors. This is a US Government work and is in the public domain in the USA. Published by John Wiley and Sons, Ltd on behalf of EMBO
EMBO Molecular Medicine
Volume 5, Issue 5, pages 691–706, May 2013
How to Cite
Spampanato, C., Feeney, E., Li, L., Cardone, M., Lim, J.-A., Annunziata, F., Zare, H., Polishchuk, R., Puertollano, R., Parenti, G., Ballabio, A. and Raben, N. (2013), Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol Med, 5: 691–706. doi: 10.1002/emmm.201202176
- Issue published online: 7 MAY 2013
- Article first published online: 18 APR 2013
- Manuscript Accepted: 27 FEB 2013
- Manuscript Revised: 25 FEB 2013
- Manuscript Received: 18 OCT 2012
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.